BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7474430)

  • 1. [Autologous bone marrow transplantation].
    Fujimori Y; Kakishita E
    Rinsho Byori; 1995 Jul; Suppl 99():9-14. PubMed ID: 7474430
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
    Geller RB
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technical aspects of autologous bone marrow transplantation].
    Handgretinger R; Klingebiel T; Niethammer D
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive autologous graft-versus-host disease induced by cyclosporin A.
    Barredo JC; Yusuf U; Hahn A; Abboud MR; Laver J
    Bone Marrow Transplant; 1996 Sep; 18(3):659-62. PubMed ID: 8879637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia.
    Prentice HG; Macdonald ID; Hamon MD
    Prog Clin Biol Res; 1994; 389():239-43. PubMed ID: 7700907
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts.
    Sieber F; Gaffney DK; Yamazaki T; Qiu K
    Prog Clin Biol Res; 1994; 389():147-54. PubMed ID: 7700897
    [No Abstract]   [Full Text] [Related]  

  • 7. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation in chronic GvHD and autoimmune diseases.
    Andolina M; Maximova N; Rabusin M; Parco S; Colovic M; Jankovic G
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():145-7. PubMed ID: 8932817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous marrow transplantation in cancer therapy.
    Herzig GP
    Prog Hematol; 1981; 12():1-23. PubMed ID: 7041172
    [No Abstract]   [Full Text] [Related]  

  • 10. [Autologous bone marrow transplantation].
    Klingebiel T; Handgretinger R; Niethammer D
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():42-5. PubMed ID: 7841780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved results in marrow transplantation from unrelated donors. Genoa BMT Group.
    Bacigalupo A; Lamparelli T; Barbanti M; Sacchi N; Battista Ferrara G; Pozzi S; Bregante S; Mordini N; Vitale V; Van Lint MT
    Haematologica; 1999 Jun; 84 Suppl EHA-4():50-2. PubMed ID: 10907467
    [No Abstract]   [Full Text] [Related]  

  • 12. Purging: elimination of malignant cells from autologous blood or marrow transplants.
    Champlin R
    Curr Opin Oncol; 1996 Mar; 8(2):79-83. PubMed ID: 8727298
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
    Alonso K; Medenica R; Morehead G
    Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
    [No Abstract]   [Full Text] [Related]  

  • 14. New approaches to treating malignances with stem cell transplantation.
    Margolis J; Borrello I; Flinn IW
    Semin Oncol; 2000 Oct; 27(5):524-30. PubMed ID: 11049020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
    Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
    Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow purging for autologous bone marrow transplantation.
    Combaret V; Favrot MC; Philip T
    Targeted Diagn Ther; 1989; 2():137-54. PubMed ID: 2519544
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of cytokines in autologous bone marrow transplantation.
    Peters WP; Ross M; Vredenburgh J; Hussein A; Meisenberg B; Gilbert C; Petros WP; Kurtzberg J
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):737-47. PubMed ID: 8344888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
    Zöller M; Matzku S
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.